Clinical Benefit of Cardiac Resynchronization Therapy With a Defibrillator in Patients With an Ejection Fraction > 35% Estimated by Cardiac Magnetic Resonance
- 1 February 2014
- journal article
- Published by Elsevier in Revista Española de Cardiología (English Edition)
- Vol. 67 (2) , 107-113
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Head-to-Head Comparison of Left Ventricular Function Assessment with 64-Row Computed Tomography, Biplane Left Cineventriculography, and Both 2- and 3-Dimensional Transthoracic EchocardiographyJACC, 2012
- The Extent of Left Ventricular Scar Quantified by Late Gadolinium Enhancement MRI Is Associated With Spontaneous Ventricular Arrhythmias in Patients With Coronary Artery Disease and Implantable Cardioverter-DefibrillatorsCirculation: Arrhythmia and Electrophysiology, 2011
- Cardiac resynchronization therapy: a meta-analysis of randomized controlled trialsCanadian Medical Association Journal, 2011
- Cardiac-Resynchronization Therapy for Mild-to-Moderate Heart FailureNew England Journal of Medicine, 2010
- Relevance of Echocardiographic Evaluation of Right Ventricular Function in Patients Undergoing Cardiac Resynchronization TherapyPacing and Clinical Electrophysiology, 2009
- The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart FailureNew England Journal of Medicine, 2005
- Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart FailureNew England Journal of Medicine, 2005
- Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated CardiomyopathyNew England Journal of Medicine, 2004
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine, 2004
- Reproducibility of quantitative two-dimensional echocardiographyAmerican Heart Journal, 1988